Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of abatacept plus mycophenolate mofetil and prednisone in lupus nephritis
jRCT2080222074Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in lupus nephritis (LN) and systemic lupus erythematosus (SLE) comparing Abatacept arm with Placebo arm (2 arms). Started May 2013; status: completed.
02
Drugs
abatacept
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on jRCT2080222074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222074.